John M. Klopp
Chief Tech/Sci/R&D Officer bij ACER THERAPEUTICS INC.
Profiel
John M.
Klopp is currently the Chief Technical Officer at Acer Therapeutics, Inc. Prior to this, he worked as the Senior Director-Manufacturing Management at Ultragenyx Pharmaceutical, Inc. from 2013 to 2018.
Mr. Klopp received his undergraduate degree from The Pennsylvania State University and his graduate degree from the University of California, Berkeley.
Actieve functies van John M. Klopp
| Bedrijven | Functie | Begin |
|---|---|---|
| ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-09-2019 |
Eerdere bekende functies van John M. Klopp
| Bedrijven | Functie | Einde |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-01-2018 |
Opleiding van John M. Klopp
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
